TAGS "US FDA"
All News US FDA In Focus US FDA BreakingNews of US FDA Your Interested Follow Story US FDA
FDA advisers narrowly recommend authorization of first antiviral pill to treat covid-19
FDA advisers narrowly recommend authorization of first antiviral pill to treat covid-19
WEDNESDAY, DECEMBER 01, 2021
Expert advisers to the Food and Drug Administration on Tuesday recommended authorization of the first coronavirus pill to prevent high-risk people from developing severe illness in a divided vote that reflects the complicated mix of benefits and risks of a new and easy mode of treatment.FDA delays decision on Moderna coronavirus vaccine for adolescents to evaluate myocarditis risk, company says
FDA delays decision on Moderna coronavirus vaccine for adolescents to evaluate myocarditis risk, company says
MONDAY, NOVEMBER 01, 2021
The Food and Drug Administration is delaying a decision on whether to make Modernas coronavirus vaccine available to adolescents because the agency needs more time to evaluate if the shot increases the risk of a rare cardiac side effect, the company said Sunday.FDA advisers back Pfizer-BioNTech coronavirus vaccine for ages 5 to 11, saying benefits outweigh risks
FDA advisers back Pfizer-BioNTech coronavirus vaccine for ages 5 to 11, saying benefits outweigh risks
WEDNESDAY, OCTOBER 27, 2021
WASHINGTON - More than 10 months after U.S. adults started receiving coronavirus vaccines, the nations younger children moved significantly closer to getting a shot of protection when advisers to the Food and Drug Administration on Tuesday endorsed the Pfizer-BioNTech vaccine.FDA panel recommends Moderna booster for people 65 and older and adults at high risk of exposure or severe illness
FDA panel recommends Moderna booster for people 65 and older and adults at high risk of exposure or severe illness
FRIDAY, OCTOBER 15, 2021
WASHINGTON - An independent advisory panel to the Food and Drug Administration on Thursday unanimously recommended a booster dose of the Moderna coronavirus vaccine for people 65 and older and for adults who are at high risk of severe illness because of underlying conditions or exposure on the job.FDA authorizes Pfizer-BioNTech coronavirus vaccine booster for older Americans and those at high risk of illness
FDA authorizes Pfizer-BioNTech coronavirus vaccine booster for older Americans and those at high risk of illness
THURSDAY, SEPTEMBER 23, 2021
WASHINGTON - The Food and Drug Administration on Wednesday authorized a Pfizer-BioNTech coronavirus booster shot for people 65 and older and adults at risk of severe illness, an effort to bolster protection for the most vulnerable Americans against the highly transmissible delta variant of the virus.FDA approves first drug to slow decline of Alzheimers disease
FDA approves first drug to slow decline of Alzheimers disease
TUESDAY, JUNE 08, 2021
WASHINGTON - The Food and Drug Administration on Monday approved the first Alzheimers treatment intended to slow cognitive decline, a move hailed by patients and advocates but sharply criticized by others who argued there was not sufficient evidence the drug works.Supreme Pharmatech successfully passed US FDA registration
Supreme Pharmatech successfully passed US FDA registration
THURSDAY, MARCH 04, 2021
Supreme Pharmatech Co, Ltd., Thailand's manufacturer of liposomal food supplement products, successfully passed US FDA registration procedure and got US FDA Certificate.Loading...
Please contact
The Nation's Editorial: thenation@nationgroup.com
Online Advertising Contact : kullapark_pho@nationgroup.com
Tel: 02-338-3000